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Our aim was to investigate the role of oxidative stress in elastase-induced pulmonary emphysema.
C57BL/6 mice were subjected to pancreatic porcine elastase (PPE) instillation (0.05 or 0.5 U per mouse, i.t.)
to induce pulmonary emphysema. Lungs were collected on days 7, 14, and 21 after PPE instillation. The
control group was sham injected. Also, mice treated with 1% aminoguanidine (AMG) and inducible NO
synthase (iNOS) knockout mice received 0.5 U PPE (i.t.), and lungs were analyzed 21 days after.
We performed bronchoalveolar lavage, biochemical analyses of oxidative stress, and lung stereology and
morphometry assays. Emphysema was observed histologically at 21 days after 0.5 U PPE treatment;
tissues from these mice exhibited increased alveolar linear intercept and air-space volume density in
comparison with the control group. TNF-a was elevated at 7 and 14 days after 0.5 U PPE treatment,
concomitant with a reduction in the IL-10 levels at the same time points. Myeloperoxidase was elevated in
all groups treated with 0.5 U PPE. Oxidative stress was observed during early stages of emphysema, with
increased nitrite levels and malondialdehyde and superoxide dismutase activity at 7 days after 0.5 U PPE
treatment. Glutathione peroxidase activity was increased in all groups treated with 0.5 U PPE. The
emphysema was attenuated when iNOS was inhibited using 1% AMG and in iNOS knockout mice.
Furthermore, proteolytic stimulation by PPE enhanced the expression of nitrotyrosine and iNOS, whereas
the PPEþAMG group showed low expression of iNOS and nitrotyrosine. PPE stimulus also induced
endothelial (e) NOS expression, whereas AMG reduced eNOS. Our results suggest that the oxidative and
nitrosative stress pathways are triggered by nitric oxide production via iNOS expression in pulmonary
emphysema.
& 2012 Elsevier Inc.Open access under the Elsevier OA license.Chronic obstructive pulmonary disease (COPD) is characterized
by chronic bronchitis and pulmonary emphysema. Emphysema is
the major cause of chronic morbidity and mortality in COPD patients
worldwide [1]. Emphysema is characterized by air-space enlarge-
ment, accompanied by the destruction of parenchymal structure.
The breakdown of the extracellular matrix in the parenchymal
tissues occurs because of the inﬂammatory response, in which
inﬂammatory cells are recruited to the lungs. There, the inﬂamma-
tory cells release a large quantity of proteinases, exceeding the
proteinase inhibitor defenses of the lung; this phenomenon is the5
lsevier OA license.basis of the well-described proteinase–antiproteinase hypothesis [2].
Beyond proteinase release, neutrophils and activated macrophages
also release reactive oxygen species owing to the respiratory burst
that occurs during the inﬂammatory process. These cells also secrete
cytokines, potentiating further inﬂammation. It is known that both
proteolytic stimulus and oxidative stress are involved in the
pathogenesis of pulmonary emphysema.
Cigarette smoking, the main risk factor for the development of
emphysema, has long been considered responsible for the oxida-
tive stress involved in this process. However, recent studies have
demonstrated that endogenous oxidative stress is involved in
proteolytic emphysema in several rodent models. Most of
these studies have investigated genes that are related to the
cellular antioxidant response, such as NF-E2-related factor 2 [3],
M. Lanzetti et al. / Free Radical Biology and Medicine 53 (2012) 1993–20011994thioredoxin 1 [4], and SOD3 (extracellular superoxide dismutase,
or ECSOD) [5]. In contrast, our study focused on evaluating the
antioxidant response in the lungs after porcine pancreatic elas-
tase stimulation at various time points of emphysema establish-
ment. We also investigated the participation of the nitrosative
stress pathway as an aggravator of protease-induced pulmonary
emphysema. A very recent study has demonstrated that inducible
nitric oxide synthase (iNOS) inhibition reverses the pulmonary
emphysema induced by cigarette smoke [6]. However, we
hypothesized that peroxynitrite synthesis, from the nitric oxide
and superoxide anion reaction, contributes to the development of
pulmonary emphysema, disturbing the antioxidant defenses and
generating oxidative damage at the cellular level.Material and methods
All procedures were approved by the Institutional Ethics Commit-
tee of the Federal University of Rio de Janeiro (DAHEICB 063).Study I
Five groups of C57BL/6 mice (n¼6) were used. Mice were
anesthetized and subjected to an intratracheal instillation of either
0.05 or 0.5 U of porcine pancreatic elastase (PPE; Sigma–Aldrich) or
saline (control group). Animals were sacriﬁced at 7, 14, and 21 days
after treatment to better comprehend the moment of the appearance
of the emphysematous lesions and at which moment the oxidative
stress is crucial for the emphysema development.Study II
To assay the role of nitric oxide in the pathogenesis of
emphysema, we inhibited iNOS by treating the animals with 1%
aminoguanidine (AMG), provided in the drinking water. AMG
treatment began 1 day before emphysema induction and con-
tinued throughout the entire emphysema time course (to 21 days
after 0.5 U of PPE). Mice were randomized into four groups (n¼5):
control, AMG, PPE, and PPEþAMG.Study III
To study the role of inducible nitric oxide synthase in the
pathogenesis of emphysema, C57BL/6 wild-type and iNOS knockout
mice were subjected to an intratracheal instillation of 0.5 U of PPE
and sacriﬁced 21 days after the treatment. Mice were randomized
into four groups (n¼5): control, PPE, control iNOS KO, and PPE
iNOS KO.Table 1
Outline of biochemical analyses.
Analysis Scope
MPO Lung injury related to neutrophils
OHpro Collagen breakdown
Nitrite Nitric oxide
SOD Antioxidant defense, mainly against superoxide anion
GPx Antioxidant defense, mainly against hydroperoxides
TBARS Lipid peroxidation
MPO, myeloperoxidase; OHpro, hydroxyproline; SOD, superoxide dismutase; GPx, glu
high dose of PPE, like 7 and 14 days; 21 days LD, low dose of PPE. All comparisons areLung histology and quantiﬁcation of emphysema
Mice were sacriﬁced by cervical displacement. Left lungs were
removed and ﬁxed with 4% paraformaldehyde. The tissue was
embedded in parafﬁn, and 5-mm-thick sections were stained with
hematoxylin and eosin (H&E). Air-space enlargement was quan-
tiﬁed by the mean linear intercept length of the distal air spaces
(Lm) in 30 randomly chosen ﬁelds of tissue sections per group [7].
The surface density of alveolar septa (Sv[alvsept]), volume density
of alveolar septa (Vv[alvsept]), and air-space volume density
(Vv[air space]) were calculated by counting the number of
structures that were intersected by the test system (partial points,
Pp) in 30 randomly chosen ﬁelds per group [8].Measurements in bronchoalveolar lavage (BAL)
BAL was performed immediately after sacriﬁce (30.5 ml
saline). The trachea was exposed and cannulated to allow access
to the airway. The BAL ﬂuid was kept on ice. Aliquots were
reserved for cell counts (performed under a microscope), and the
remaining BAL was centrifuged (600g). Aliquots of the super-
natant were subjected to ELISA to measure secreted TNF-a and
IL-10, Bradford assays to measure protein content [9], myeloper-
oxidase (MPO) assay [10], and a colorimetric hydroxyproline
assay (OHpro) [11,12]. An outline of the MPO and OHpro assays
can be seen in Table 1. Reactive oxygen species (ROS) detection
was performed in BAL cells following the adapted nitroblue
tetrazolium chloride (NBT) protocol [13]. Brieﬂy, ROS produced by
cells reacted with NBT, generating blue formazan. Optical density
was read in a microplate reader (Bio-Rad Model 550; Hercules,
CA, USA) at 630 nm. All assays were conducted as previously
described.Measurements in lung homogenates
Right lungs were removed and homogenized in potassium
phosphate buffer. The homogenate was centrifuged (600g) and
the supernatant was removed. Protein concentration was esti-
mated using the Bradford method [9]. The outline of the bio-
chemical analyses can be seen in Table 1. Nitrite levels were
determined by a method based on the Griess reaction [14]. SOD
activity was determined as described by Bannister and Calabrese
[15]. Glutathione peroxidase (GPx) activity was measured as
described by Flohe and Gunzler [16]. Lipid peroxidation was
measured using a thiobarbituric acid-reactive substances assay
(TBARS) as a marker of oxidative damage [17]. Western blots
were used to analyze the expression of iNOS, endothelial (e) NOS,
and nitrotyrosine. The antibodies against iNOS (Cayman Chemical
Co., Ann Arbor, MI, USA), eNOS, and nitrotyrosine (Santa Cruz
Biotechnology, Santa Cruz, CA, USA) were diluted 1/1000. Tubulin
(Santa Cruz Biotechnology) was used as an internal control. Equal
loading of the samples was ensured by protein quantiﬁcation7 days 14 days 21 days HD 21 days LD
mmm m mm —
mm — mmm —
m — mm —
m — — —
mmm mmm mmm mmm
m m — —
tathione peroxidase; TBARS, thiobarbituric acid-reactive substances. 21 days HD,
relative to the control group.
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conﬁrm equal loading.
Statistical analyses
The data were compared using one-way ANOVA followed by
Bonferroni post hoc test (means7SEM, po0.05). Statistical
analyses were performed in GraphPad Prism software (GraphPad
Software, San Diego, CA, USA).Results
Lung emphysema induced by PPE is time- and dose-dependent
To evaluate the various stages of emphysema development and
determine whether it is PPE dose-dependent, we exposed mice to
0.5 and 0.05 U of PPE and observed the lung histology at 7, 14, and 21
days after instillation. For the lowest dose (0.05 U of PPE), we
analyzed only the 21-day time point. H&E-stained histological sec-
tions revealed normal lung structure in the control group. At 7 days
post-PPE instillation (0.5 U), no changes in the lung parenchymawere
observed. At 14 days post-PPE, some alveolar increase was observed,
and at 21 days, complete emphysema had occurred, with the
signiﬁcant enlargement of alveolar spaces distributed throughout
the parenchyma (Fig. 1A–E). To further characterize the establishment
of emphysema, histological ﬁndings were quantiﬁed in the lungFig. 1. H&E-stained lung parenchyma. The tissues shown are from (A) mice in the salin
days postinstillation, respectively; and (E) mice treated with 0.05 U of PPE, at 21 day
alveolar enlargement. Scale bar, 100 mm.
Table 2
Lung morphological and stereological quantiﬁcations after PPE-induced emphysema.
Control PPE 0.5 U
7 days
Lm (mm) 48.1271.25 52.2973.86
Sv (mm1) 0.08370.002 0.07870.005
Vv[alvsept] (%) 53.770.86 51.672.57
Vv[air space] (%) 46.270.86 48.472.57
Lm, mean linear intercept length of distal air spaces; Sv, surface density of alveolar septa
spaces; PPE, porcine pancreatic elastase. The results shown represent the means7SEM
n po0.01 compared with control group.slices. As shown in Table 2, all histological abnormalities typical of
emphysema were observed in the tissues collected at 21 days post-
PPE 0.5 U instillation, including increased Lm and Vv[air space],
accompanied by decreased Sv[alvsept] and Vv[alvsept].PPE (0.5 U) triggers chronic inﬂammatory response with early
cytokine modulation in BAL
Cell counts were conducted in BAL to evaluate leukocyte
migration; increased numbers of cells were found only at 21 days
post-PPE 0.5 U instillation (Fig. 2A). However, the response at the
cytokine secretion level occurred at earlier time points. The
proinﬂammatory TNF-a was elevated at 7 and 14 days post-PPE
0.5 U instillation, whereas the anti-inﬂammatory IL-10 was
reduced at the same time points (Fig. 2B and C). An increase in
myeloperoxidase was observed at 7 days (po0.001) and per-
sisted at 14 and 21 days after the instillation of 0.5 U of PPE
(Fig. 2D, Table 1), characterizing a high number of activated
neutrophils in the airways. In contrast, the hydroxyproline levels
detected in the BAL were increased at 7 days (po0.01), reduced
to baseline (i.e., levels similar to those of the control group) at 14
days, and increased again (po0.001) at 21 days after instillation
of 0.5 U of PPE (Fig. 2E, Table 1), showing a cyclic extracellular
matrix remodeling by turnover of collagen. None of the evaluated
parameters were altered in the group treated with 0.05 U of PPE
for 21 days.e control group, at 21 days; (B–D) mice treated with 0.5 U of PPE, at 7, 14, and 21
s postinstillation. Arrows indicate septal wall tissue destruction and consequent
PPE 0.05 U, 21 days





; Vv[alvsept], volume density of alveolar septa; Vv[air space], volume density of air
; n¼6/group.
Fig. 2. Inﬂammatory parameters involved in the establishment of emphysema. BAL samples were used to detect (A) total leukocytes, (B) TNF-a cytokine levels, (C) IL-10
cytokine levels, (D) myeloperoxidase activity, and (E) hydroxyproline levels. Signiﬁcant differences compared to the control: *po0.05, **po0.01, ***po0.001. n¼6/group.
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injury
Nitrite levels can be used as an indirect measurement of nitric
oxide, a physiologic molecule that can be enhanced in the
inﬂammatory process and contribute to oxidative and nitrosative
stress. Nitrite levels were increased at 7 days after the instillation
of 0.5 U of PPE (po0.05), returned to baseline at 14 days, and
increased again (po0.01) at 21 days (Fig. 3A, Table 1). Mean-
while, antioxidant enzymes exhibited different temporal response
patterns. Superoxide dismutase activity was increased only at
7 days after instillation of 0.5 U of PPE (po0.05; Fig. 3B, Table 1),
whereas glutathione peroxidase was enhanced at all time points
tested (po0.001; Fig. 3C, Table 1). Further demonstrating that
oxidative stress is more evident at early time points, the groups at
7 and 14 days after instillation of 0.5 U of PPE exhibited elevated
levels of TBARS (po0.05; Fig. 3D), a marker of oxidative damage.Aminoguanidine treatment attenuates lung emphysema
To verify that nitric oxide is involved in the elastolytic model
of emphysema, mice subjected to the instillation of 0.5 U of PPE
were treated with 1% AMG for 22 days, beginning 1 day before the
PPE treatment. Lung histology showed that mice treated with 1%
AMG alone were indistinguishable from those in the control
group (Fig. 4A), with normal alveolar spaces and preserved septa
(Fig. 4B). PPE-treated mice exhibit lesions typical of emphysema,
with increased alveolar spaces and evident septal destruction
(Fig. 4C), as described above. However, the PPEþAMG-treated
mice showed relatively well-preserved lung parenchyma, with
better maintained alveolar septa and consequently better pre-
served alveolar spaces than the PPE group (Fig. 4D). As shown in
Table 3, all histological alterations typical of emphysema were
observed at 21 days post-PPE 0.5 U instillation, including
increased Lm and Vv[airspaces], accompanied by decreased
Sv[alvsept] and Vv[alvsept]. However, treatment with 1% amino-
guanidine effectively attenuated the effects of PPE on the lungs,and the PPEþAMG group was indistinguishable from the
control group.
AMG decreases inﬂammatory inﬁltrate and protein nitration induced
by PPE
BAL cell counts showed that PPE induced an increase in
leukocyte migration (po0.001) compared to the control group.
In contrast, the cell counts in the PPEþAMG group were similar to
those in the controls and were reduced (po0.001) compared to
the PPE group (Fig. 5). Western blotting analysis showed that
treatment with 1% aminoguanidine partially inhibited iNOS
expression (Fig. 6). Nevertheless, AMG effectively prevented
PPE-induced iNOS overexpression in the PPEþAMG group. Sur-
prisingly, the PPEþAMG group also exhibited a reduction in eNOS
expression compared to the PPE group. As a consequence of iNOS
and eNOS overexpression, the PPE group exhibited elevated
nitrotyrosine, a marker of nitrosative stress, whereas AMG treat-
ment effectively prevented protein nitration; lower nitrotyrosine
expression was observed in the PPEþAMG group compared to the
PPE group.
iNOS deﬁciency protects against PPE-induced emphysema
To better characterize the role of iNOS in the progression of
emphysema a separate group of C57BL/6 wild-type and iNOS/
mice were exposed to PPE. Lung histology and morphometry/
stereology were assayed to evaluate the pulmonary architecture.
Total leukocyte numbers were quantiﬁed and ROS levels were
analyzed as a parameter of oxidative stress. Lung histology
showed that control iNOS/ mice were similar to the control
wild-type group (Fig. 7A), with normal alveolar spaces and
preserved septa (Fig. 7B). PPE-treated mice exhibited lesions
typical of emphysema, with increased alveolar spaces and evident
septal destruction (Fig. 7C), as described above. However, PPE
iNOS/ mice showed intact alveolar septa and consequently
better preserved alveolar spaces than the PPE group (Fig. 7D).
Table 4 conﬁrms all the typical changes in the PPE WT group, with
Fig. 3. Markers of oxidative stress involved in the establishment of emphysema. (A) Nitrite levels, (B and C) SOD and GPx activity, and (D) TBARS were measured in lung
tissue samples. Signiﬁcant differences compared to the control: *po0.05, **po0.01, ***po0.001. n¼6/group.
Fig. 4. H&E-stained lung parenchyma after 1% AMG treatment. The tissues shown are from (A) mice in the saline group, at 21 days postinstillation; (B) mice treated with
1% AMG in the drinking water; (C) mice treated with 0.5 U of PPE, at 21 days postinstillation; (D) mice treated with 0.5 U of PPE and treated with 1% AMG in the drinking
water, at 21 days postinstillation. Arrows indicate septal wall tissue destruction and consequent alveolar enlargement. Scale bar, 100 mm.
M. Lanzetti et al. / Free Radical Biology and Medicine 53 (2012) 1993–2001 1997a signiﬁcant improvement in the PPE iNOS/ group. The phe-
notype is better in PPE iNOS/ mice than in the PPE WT group,
because this group presented a reduction in total leukocyte
numbers (po0.01) and ROS levels (po0.001; Fig. 7E and F).Discussion
Our results demonstrate a critical interaction between different
pathways involved in pulmonary emphysema, whereby proteolytic
Table 3
Lung morphological and stereological quantiﬁcations after PPE-induced emphysema and AMG treatment.
Control AMG PPE PPEþAMG
Lm (mm) 45.5371.79 49.9672.65 68.3171.55n 57.2476.47
Sv (mm1) 0.08870.004 0.08070.004 0.05970.001n 0.06570.008
Vv[alvsept] (%) 49.2071.53 46.2071.16 39.6772.60n 42.6772.96
Vv[air space] (%) 50.8071.53 53.8071.16 62.0072.60n 57.3372.96
Lm, mean linear intercept length of distal air spaces; Sv, surface density of alveolar septa; Vv[alvsept], volume density of alveolar septa; Vv[air space], volume density of air
spaces; PPE, porcine pancreatic elastase; AMG, aminoguanidine. The results represent the means7SEM; n¼5/group.
n po0.05 compared with control group.
Fig. 5. The inhibition of iNOS by aminoguanidine treatment prevented inﬂamma-
tory inﬁltration. Total leukocytes were counted. Signiﬁcant difference compared to
the control, ***po0.001, and signiﬁcant difference compared to the PPE group,
###po0.001. n¼5/group.
Fig. 6. The inhibition of iNOS by aminoguanidine treatment prevented nitrosative
stress. Western blots were used to detect iNOS, eNOS, and nitrotyrosine. Each
Western blot had its own tubulin loading control. Densitometry of the bands was
calculated and normalized to loading control. Statistical difference compared to
the control, *po0.05, and signiﬁcant difference compared to the PPE group,
#po0.05. n¼3 or 4/group.
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tion at different time points during the establishment of emphy-
sema. An interesting fact is observed at 21 days after stimulation; at
this time point the emphysema is completely installed and any
changes linked to antioxidant enzyme activities are observed. The
changes in antioxidant enzyme activities were observed at the initial
stage of emphysema establishment, when the ﬁnal lesions have yet
to be developed. This demonstrates that oxidative stress participates
in the evolution of pulmonary emphysema, even in a proteolytic
model. We also demonstrate that intervention in nitric oxide
synthesis may be a promising strategy for the treatment of emphy-
sema because mice exposed to proteolytic stimuli suffered nitrosa-
tive stress and presented enhanced nitrotyrosine expression, a
marker of nitrosative damage. Aminoguanidine treatment inhibited
this process, thus preventing this complication and attenuating
septal tissue destruction.
There is a rationale explaining the relationship between inﬂam-
mation and oxidative stress in this model. When elastase is instilled
and reaches the airways, tissue destruction processes are initiated.
Then, inﬂammatory cells are activated and migrate to the alveolar
spaces to neutralize the harmful stimulus [18]. However, the pro-
teases and ROS are inherent by-products of activated leukocytes and
contribute to the inﬂammatory response and parenchyma destruction
[19–21]. Additionally, the direct increase in the oxidative burden
produced by the release of oxygen radicals from inﬂammatory
neutrophils and macrophages contributes to the establishment of
an oxidative stress [22]. Even a single exposure to PPE is sufﬁcient to
trigger a continuous degradation process because peptides derived
from the extracellular matrix (ECM) are chemotactic for inﬂammatory
cells, suggesting that ECM destruction may be a self-perpetuating
process [23].The protocol used in this study effectively produced emphy-
sematous lesions in a dose-dependent manner; a low dose of
0.05 U of PPE did not induce structural lung alterations. On the
other hand, mice exposed to 0.5 U of PPE underwent typical
emphysematous tissue destruction, as indicated by several mor-
phological/stereological parameters. Increased Lm and decreased
Sv and Vv[alvsept] demonstrate accelerated tissue destruction,
increasing Vv[air space] to produce enlarged alveolar spaces. All
of these histological measures are well-established features of
pulmonary emphysema [24,25]. Associated with these histologi-
cal changes, elevated leukocyte recruitment was observed in the
BAL of the group observed 21 days after PPE instillation (0.5 U),
i.e., the emphysema group, demonstrating that the presence of
inﬂammatory cells is linked to emphysema [5]. However, leuko-
cyte inﬁltration was not observed at 7 and 14 days after PPE
instillation, even though an increase in TNF-a cytokine secretion
Fig. 7. iNOS-deﬁcient mice are more protected against emphysema than wild type. Lung parenchyma H&E-stained sections 21 days postinstillation are shown. (A) Wild-
type control group, (B) wild-type PPE group, (C) iNOS/ control group, (D) iNOS / PPE group. (E) Total leukocytes. (F) ROS detection. Scale bar, 100 mm. Statistically
different compared to control WT group, *po0.05, **po0.01, and statistically different compared to PPE WT group, #po0.05. ##po0.01, ###po0.001. n¼5/group.
Table 4
Lung morphological and stereological quantiﬁcations in WT and iNOS/ mice instilled or not with PPE.
CTR WT PPE WT CTR iNOS / PPE iNOS/
Lm (mm) 42.5571.41 77.3674.90** 41.9671.48## 49.0172.73
Sv (mm1) 0.09470.003 0.05370.003** 0.09670.003## 0.08370.005
Vv[alveolar septa] (%) 61.772.21 36.772.34* 66.371.60### 53.973.18
Vv[air space] (%) 38.372.21 63.372.34* 33.771.60### 46.173.18
Lm, mean linear intercept length of distal air spaces; Sv, surface density of alveolar septa; Vv[alvsept], volume density of alveolar septa; Vv[air space], volume density of air
spaces; PPE, porcine pancreatic elastase. The results represent the means7SEM. n¼5/group.
n po0.05 vs wild-type control mice.
nn po0.01 vs wild-type control mice.
## po0.01 vs wild-type PPE mice.
### po0.001 vs wild-type PPE mice.
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actions of resident cells, such as alveolar epithelial cells or even
resident macrophages, neutrophils, and lymphocytes, which
initiated the inﬂammatory process by releasing the Th1 cytokine.
Although these cells were not obviously increased in number, it is
possible that they were more activated after PPE instillation. At
the same time, a reduction in IL-10 cytokine levels was observed,
indicating a proinﬂammatory proﬁle with an increase in stimu-
latory cytokines and decrease in modulatory cytokines in the lung
environment. Under normal physiological conditions, IL-10 inhi-
bits the secretion of proinﬂammatory cytokines such as TNF-aand IFN-g, suppressing the proliferation of T cells, NK cells, and
alveolar macrophages [26]. However, under stimulatory condi-
tions, IL-10 cannot carry out these immunomodulatory effects,
favoring increased secretion of TNF-a and contributing to inﬂam-
mation. Considering that few cells migrated to the alveolar spaces
at 7 days, as shown in Fig. 2A, it is likely that the cells present
were more active, i.e., they secreted more TNF-a. This rationale is
consistent with the myeloperoxidase activity, which was
increased beginning at 7 days after PPE instillation. Increased
myeloperoxidase activity indicates the presence of neutrophil
activity and is also a considerable aggravating factor for oxidative
M. Lanzetti et al. / Free Radical Biology and Medicine 53 (2012) 1993–20012000stress because its reaction with H2O2 generates hypochlorous
acid, which can react with the superoxide anion to form a
hydroxyl radical, one of the strongest ROS [27]. It is surprising
that variations in inﬂammatory mediators and oxidative stress
markers occurred at 7 days after induction of emphysema,
whereas the leukocytes in the BAL did not increase until 21 days,
especially when at this time while the number of leukocytes was
increasing, the markers TNF-a, IL-10, SOD, and TBARS had
returned to control values. But inﬂammation ﬁrst occurred in
alveolar septa and later in the alveolar space. Inﬂammatory
mediators and redox markers were assayed in lung homogenates,
whereas leukocyte numbers were quantiﬁed in BAL. So, we
suggest a temporal response between parenchyma and BAL that
is proportional to the variation observed in our study. Thus TNF-a,
IL-10, SOD, and TBARS were reduced in lung homogenates,
because major leukocyte numbers were found at this time in
the BAL.
The hydroxyproline proﬁle is especially interesting. Hydroxypro-
line levels were elevated at 7 days, returned to baseline levels at 14
days, and increased again at 21 days after PPE instillation. The
detection of OHpro in BAL is an indirect way to assess connective
tissue/extracellular matrix breakdown [12,25]. Thus, the elevated
levels of OHpro in BAL after PPE stimulus suggest that the break-
down of septal tissue was accelerated at speciﬁc time points,
compromising the pulmonary architecture. This could be caused
by protease release from inﬂammatory and epithelial cells or
through the chemotactic action of peptides derived from the ECM,
contributing to continuous tissue destruction [23].
The hydroxyproline response proﬁle was paralleled by nitrite
levels, which were increased at 7 days, reduced to control levels
at 14 days, and increased again at 21 days after PPE instillation.
This pattern of behavior suggests that a kinetic response is
involved during the establishment of emphysema. Apparently,
an initial response is triggered by PPE stimulation and associated
effects, followed by a more stable stage featuring a ‘‘pseudo-
effective’’ combating of the PPE effects and ending with a rebound
elevation of speciﬁc markers during the emphysema phase. The
NO involvement at various stages of emphysema suggests that it
plays a pivotal role in the pathogenesis of emphysema and
encouraged us to explore the underlying pathways. However,
these data cannot be interpreted independently because NO is
likely to interact with other molecules. Under physiological
conditions, the superoxide anion is rapidly removed by high
concentrations of scavenging enzymes called superoxide dismu-
tases, and NO is rapidly removed by diffusion through tissues into
red blood cells [28,29], where it is converted to nitrate/nitrite.
However, under proinﬂammatory conditions, the production of
superoxide and NO is simultaneously strongly activated, increas-
ing the production of both molecules by 1000-fold [30]. These
conditions favor the formation of the strong oxidant peroxyni-
trite, which is produced by the collision of NO and superoxide.
Elevated SOD and nitrite levels were observed at 7 days after
PPE, indirectly indicating a parallel increase in O2
 and NO
production with consequent dismutation and conversion, respec-
tively. In contrast, both were decreased at 14 days after PPE
instillation, suggesting the involvement of peroxynitrite forma-
tion, with NO and superoxide reacting so quickly that SOD activity
was not required. However, at 21 days, when emphysema was
established, nitrite elevation was observed again but not accom-
panied by elevation in SOD activity, suggesting a possible failure
of the antioxidant system and free peroxynitrite synthesis.
Oxidative stress is more evident at the initial phase of the
establishment of emphysema than when the emphysema is fully
developed. As shown by the time course after PPE instillation,
SOD was elevated at 7 days; GPx was elevated at 7, 14, and 21
days; and TBARS, a recognized marker of oxidative damage by lipidperoxidation, was elevated at 7 and 14 days. These results clarify an
important aspect of proteolytic emphysema, showing that oxidative
stress is in fact involved in its establishment and progression.
Additionally, these data highlight several parameters that should
be considered markers of oxidative stress in proteolytic emphysema.
Beyond the establishment of inﬂammation and oxidative stress
conditions, PPE triggered additional interacting pathways. The
stimulation of iNOS expression favors the enhanced production of
NO, which is involved in inﬂammatory responses. These increases in
NO levels could facilitate dangerous levels of peroxynitrite synthesis,
which can react with tyrosine residues to form nitrotyrosine [22,31].
Because NO moves so readily through membranes and between
cells, it can react with superoxide even if it has not been produced
within the same cell [30]. To understand the participation of nitric
oxide and its potential to react with superoxide anion to form
peroxynitrite during the development of emphysema, animals were
cotreated with aminoguanidine, a selective inhibitor of iNOS. The
data from these experiments show that PPE induced nitration
reactions, as demonstrated by the elevated nitrotyrosine expression,
which is also observed in COPD patients [31]. Our data corroborate
that of a recent study, which used another iNOS-selective inhibitor,
L-NIL, to show that iNOS plays a crucial role in tobacco-smoke-
induced emphysema [31]. Our data reinforce the critical role of iNOS
activity during the development of proteolytic emphysema and
highlight aminoguanidine as a good therapeutic strategy. A previous
study from our group showed that an inhibitor (L-NAME) and a
substrate (L-arginine) of NO synthesis have different effects on the
emphysema caused by cigarette smoke, a source of oxidants [32].
The mechanism of action of the inhibitor used before is nonselective,
because L-NAME is analogous to L-arginine, implying a competition
for NO synthesis [33]. However, the mechanism of action of amino-
guanidine is different because it acts preferentially on the inducible
isoform of nitric oxide synthase [34]. Thus, a speciﬁc inhibition
enables a better characterization of the pathway involved in the
pathogenesis of emphysema. Nevertheless, in this study we used an
elastase model of emphysema, which is not a source of oxidants, to
prove that the oxidative and nitrosative pathways are involved in the
process of induction of emphysema per se, regardless of the causative
stimulus. The low iNOS expression observed in both groups treated
with 1% AMG suggests that the inhibition of iNOS was incomplete.
Nevertheless, 1% AMG effectively inhibited nitration and may also
have modulated eNOS expression in response to PPE. According to
Laszlo et al. [35], AMG is a dual constitutive and inducible nitric oxide
synthase inhibitor. However, a review published in 2001 [36]
compared different inhibitors of NOSs and showed that AMG has a
partially selective action between iNOS and eNOS, being 11 times
more selective for iNOS than for eNOS. Furthermore, they proposed a
break in the paradigm, afﬁrming that the activity of constitutive
neuronal and endothelial NOSs can be regulated by various factors.
Thus, we suggest that the proposed treatment (1% AMG) partially
inhibited iNOS expression and avoided the overexpression of the
constitutive isoform eNOS, slightly increased by PPE. Above all,
treatment with 1% AMG improved the pulmonary histoarchitecture,
preventing alveolar damage and inﬂammatory inﬁltration.
Compared to our study, a recent study published by Boyer
et al. [37] showed contradictory results, concluding that neither
eNOS nor iNOS is required for the development of elastase-
induced emphysema. Although they found an increased number
of 3-nitrotyrosine-positive cells in lung from PPE wild-type mice,
they did not ﬁnd any improvement in lung parenchyma of neither
iNOS- or eNOS-deﬁcient mice nor of mice treated with 1400W, an
important iNOS-selective inhibitor. Perhaps these contradictory
data are justiﬁed by crucial discrepancies between the two
emphysema models. The previous one induced emphysema with
a 10 times higher dose of PPE from elastin products compared to
our study. Even with this elevated dose (5 U of PPE/mouse), our
M. Lanzetti et al. / Free Radical Biology and Medicine 53 (2012) 1993–2001 2001results regarding the Lm parameter were more signiﬁcant than
those presented in that study (po0.01 and po0.05, respectively).
Regarding the pharmacologic inhibition established with 1400W,
it is possible that it achieved total iNOS inhibition because it is 30
times more selective for iNOS than for eNOS [38]. We suggest that
1% AMG partially inhibited iNOS, as we showed by Western blot.
Maybe this modulation has a crucial role in the progression of
proteolytic pulmonary emphysema. Surprisingly, our results from
PPE iNOS/ mice corroborate our previous data showing that
iNOS-deﬁcient mice instilled with PPE showed preservation of
morphometric parameters such as Lm, Sv, and Vv of air space and
septa and also avoided an increase in leukocyte numbers and ROS
levels, which were increased in the PPE wild-type group. Thus, we
suggest that a modulation of iNOS in both inﬂammatory and
chronic processes such as COPD plays a fundamental role in
attenuating its effects.
In conclusion, we have found a trio of pathways involved in the
pathogenesis of pulmonary emphysema induced by proteolytic
perturbation. Inﬂammation, oxidative stress, and nitrosative stress
seem to be important variables that affect the development of
emphysema. A limitation of our study was that we did not assay
shorter time points of elastase stimulus, which could provide more
information about the initial oxidative stress response to the devel-
opment of emphysema. But one novel ﬁnding of this study is that
oxidative stress plays a pivotal role at the initial phase of this disease.
Nitrosative stress was observed at 21 days after PPE treatment, when
emphysema had been fully installed, and aminoguanidine treatment
concomitant with emphysema induction attenuated the proteolytic
effects induced by PPE. Our results suggest that oxidative and
nitrosative stresses generated by nitric oxide production via iNOS
expression are critical in elastase-induced emphysema.Acknowledgments
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